309 related articles for article (PubMed ID: 1277139)
1. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
Cohen SM; Wittenberg JF; Bryan GT
Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
[TBL] [Abstract][Full Text] [Related]
2. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
Grossman HB; Sonda LP; Lesser ML
Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
[TBL] [Abstract][Full Text] [Related]
3. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Cohen SM; Murasaki G; Fukushima S; Greenfield RE
Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
[No Abstract] [Full Text] [Related]
4. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Wang CY; Hayashida S; Pamukcu AM; Bryan GT
Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM
Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
Johansson SL; Anderström C; von Schultz L; Larsson P
Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325
[TBL] [Abstract][Full Text] [Related]
7. Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder.
Murasaki G; Cohen SM
Carcinogenesis; 1983; 4(1):97-9. PubMed ID: 6821891
[TBL] [Abstract][Full Text] [Related]
8. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Fukushima S; Friedell GH; Jacobs JB; Cohen SM
Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
[TBL] [Abstract][Full Text] [Related]
9. Production of urinary tract tumors by co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in F344 rats.
Wang CY; Kamiryo Y; Hayashida S; Croft WA
Cancer Lett; 1987 Mar; 34(3):249-55. PubMed ID: 3828979
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
Imaida K; Wang CY
Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637
[TBL] [Abstract][Full Text] [Related]
11. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Cohen SM; Hasegawa R; Sakata T; Johansson SL
Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
[TBL] [Abstract][Full Text] [Related]
12. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Jacobs JB; Arai M; Cohen SM; Friedell GH
Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108
[TBL] [Abstract][Full Text] [Related]
13. Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion.
Birt DF; Julius AD; Hasegawa R; St John M; Cohen SM
Cancer Res; 1987 Mar; 47(5):1244-50. PubMed ID: 3815336
[TBL] [Abstract][Full Text] [Related]
14. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
[TBL] [Abstract][Full Text] [Related]
15. Long term dose response study of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced urinary bladder carcinogenesis.
Arai M; St John M; Fukushima S; Friedell GH; Cohen SM
Cancer Lett; 1983 Apr; 18(3):261-9. PubMed ID: 6850560
[TBL] [Abstract][Full Text] [Related]
16. Effect of dose on urinary bladder carcinogenesis induced in F344 rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Arai M; Cohen SM; Jacobs JB; Friedell GH
J Natl Cancer Inst; 1979 Apr; 62(4):1013-6. PubMed ID: 285273
[TBL] [Abstract][Full Text] [Related]
17. Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats.
Wang CY; Hayashida S
Cancer Lett; 1984 Aug; 24(1):37-43. PubMed ID: 6548659
[TBL] [Abstract][Full Text] [Related]
18. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide.
Cohen SM; Tatematsu M; Shinohara Y; Nakanishi K; Ito N
J Natl Cancer Inst; 1980 Jul; 65(1):145-8. PubMed ID: 6930511
[TBL] [Abstract][Full Text] [Related]
19. Effect of dose on the induction of urothelial proliferation by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and its relationship to bladder carcinogenesis in the rat.
Hasegawa R; Cohen SM; St John M; Cano M; Ellwein LB
Carcinogenesis; 1986 Apr; 7(4):633-6. PubMed ID: 3698195
[TBL] [Abstract][Full Text] [Related]
20. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Hosaka Y; Muramatsu M; Matsushima T; Niijima T; Nagase S
Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
